Thursday, June 05, 2025 3:37:23 PM
exwannabe,
You were the one questioning the rational for the cost of keeping the London College site operating and now there is this opportunity for point of service with Flaskworks being done there eventually. Seems pretty obvious that NWBO would start small and then expand. London College seems well suited for that with artisan and Flaskworks capability.
Then there is the pilot program for MHRA and NICE working together to get reimbursement decisions timed up with approval. What are the requirements for disclosure of submissions to NICE under that program? I am not aware of them and it seems more like back and forth between MHRA and NICE with regard to info updates that leads to a timing decision for when to recommend submitting a formal request for reimbursement by NWBO or other which then has a very expedited review time because almost all pertinent info has been shared. In the mean time they plan on having 60% of all applications given a decision by 240 days from submission vs 40% which offers real hope for reimbursement in just 8 months if 240 days ever really means 240 days; ). Best wishes.
You were the one questioning the rational for the cost of keeping the London College site operating and now there is this opportunity for point of service with Flaskworks being done there eventually. Seems pretty obvious that NWBO would start small and then expand. London College seems well suited for that with artisan and Flaskworks capability.
Then there is the pilot program for MHRA and NICE working together to get reimbursement decisions timed up with approval. What are the requirements for disclosure of submissions to NICE under that program? I am not aware of them and it seems more like back and forth between MHRA and NICE with regard to info updates that leads to a timing decision for when to recommend submitting a formal request for reimbursement by NWBO or other which then has a very expedited review time because almost all pertinent info has been shared. In the mean time they plan on having 60% of all applications given a decision by 240 days from submission vs 40% which offers real hope for reimbursement in just 8 months if 240 days ever really means 240 days; ). Best wishes.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
